Rutgers University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Rutgers University sits in the top decile of US sponsors by registered trial count (#801 of 15,742 sponsors by registered trial count).

18 total trials 1 currently recruiting 15 completed early-phase tilt top decile by trial count

Rutgers University: 18 sponsored US clinical trials, 1 recruiting.

Rutgers University sponsors 18 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 15 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Weight Loss, with 2 trials.

Top-decile sponsor footprint

Rutgers University ranks in the top decile of sponsors by registered trial count (#801 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 60/100

15 of 17 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

18 total, page 1 of 1

RECRUITING

Studies of Brain and Body Interaction

NCT03672266

COMPLETED NA

Effects of TENS and Mindfulness Meditation in Persons With HIV-related Neuropathy

NCT04868123

TERMINATED NA

Use Surveillance Technology to Reduce Elder Abuse Recidivism

NCT04563728

COMPLETED NA

Using Combined EEG and Non-invasive Brain Stimulation to Examine and Improve Reward Functioning in Opioid Use Disorder

NCT04432493

COMPLETED NA

Taste Perception, Salivary Proteins & the Oral Microbiome

NCT04107688

COMPLETED Phase 2

Exercise Dose and Metformin for Vascular Health in Metabolic Syndrome

NCT03355469

COMPLETED NA

Prolene Versus Ethibond for Cervical Cerclage

NCT03311867

COMPLETED NA

KT Intervention to Increase Use of Outcome Measures

NCT04052503

COMPLETED NA

Satiety and Glucose Indices in Adults

NCT02929849

COMPLETED NA

Bitter Taste and Weight Loss in Women

NCT01856660

COMPLETED NA

Evaluation of Learning-Theory-Based Smoking Cessation Strategies

NCT01368653

COMPLETED NA

The Effect of Brown Adipose Tissue Activation on Insulin Sensitivity in Humans

NCT01791114

TERMINATED NA

The Effect of Severe Weight Loss and Protein Intake on Bone

NCT00472680

COMPLETED NA

Vitamin D Supplementation in Obesity and Weight Loss (3DD Study)

NCT01631292

COMPLETED NA

Transdiagnostic Behavioral Activation Therapy for Youth Anxiety and Depression

NCT01829100

COMPLETED NA

The Effect of Weight Loss and Dietary Protein Intake on Bone

NCT00473031

COMPLETED NA

The Effect of Vitamin D Supplementation During Caloric Restriction on Intestinal Calcium Absorption

NCT00472654

COMPLETED NA

The Effect of Weight Loss on Bone in Men

NCT00472745

What is open in the Rutgers University pipeline

1 recruiting of 18 indexed (6% open); 15 completed (83%).

Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).

Top condition: Weight Loss (2 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Rutgers University: open-pipeline peers nationwide

Peers matched on 18 registered trials and 6% open enrollment, not the therapeutic-area sidebar.

Rutgers University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 17.917.91818.1 0%10%20%30%40% Total trials Recruiting share Rutgers UniversityADC Therapeutics S.A.Akros PharmaAO Clinical Investigation and Publishing DocumentationAO Innovation Translation CenterBoston CollegeCytoDynDendreonIntercept Pharmaceuticals
Rutgers University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Rutgers University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 18 trials (± recruiting share)

Sponsors near 6% open enrollment (± trial volume)

What to do with this Rutgers University page

18 registered trials is a research-attention snapshot, not an endorsement of Rutgers University or any single study.

  • 1 of Rutgers University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Weight Loss is the condition Rutgers University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Weight Loss trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Rutgers University pipeline card: 18 registered trials from official public datasets.Report a data error.